Patents by Inventor Anthony Wilson

Anthony Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11286751
    Abstract: A power source system including a plurality of cells. The power source system uses electrical charge or current generated by a reaction in at least one of the cells to provide at least one operating material to at least one other of the cells. Optionally, the power source system uses the electrical charge generated by the reaction in the at least one of the cells to provide the at least one operating material to the at least one other of the cells only when the state of charge of the at least one of the cells is equal to or below a threshold or when the use of the cell is equal to or above a threshold. Optionally, in an initial or non-operational state, one or more or each of the cells is dry or without the at least one operating material and the power source system is configured to selectively switch at least one of the plurality of cells from the non-operational state to an operational state by providing the at least one operating material to the at least one cell.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: March 29, 2022
    Assignee: SWELLFIX UK LIMITED
    Inventors: John Hunter, Anthony Wilson, Matthew Ramsey Thorpe, Joyce Ann Rosie
  • Patent number: 11220905
    Abstract: An apparatus for controlling water production in a wellbore comprises a body in the form of a base pipe, the base pipe having an axial flow passage in the form of axial throughbore and a lateral flow passage in the form of radial port. A shroud is disposed around the base pipe and forms a housing of the apparatus. In use, the apparatus forms part of a completion string for location in the wellbore, the apparatus configured to direct production fluid into a production conduit for recovery to surface, perform a quantitative measurement of water content within the production fluid, and vary the fluid flow in the fluid flow path based on the quantitative measurement of water content within the production fluid to maintain water production at or below a predetermined threshold.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: January 11, 2022
    Assignee: Swellfix UK Limited
    Inventors: John Hunter, Anthony Wilson
  • Publication number: 20200240266
    Abstract: An apparatus for controlling water production in a wellbore comprises a body in the form of a base pipe, the base pipe having an axial flow passage in the form of axial throughbore and a lateral flow passage in the form of radial port. A shroud is disposed around the base pipe and forms a housing of the apparatus. In use, the apparatus forms part of a completion string for location in the wellbore, the apparatus configured to direct production fluid into a production conduit for recovery to surface, perform a quantitative measurement of water content within the production fluid, and vary the fluid flow in the fluid flow path based on the quantitative measurement of water content within the production fluid to maintain water production at or below a predetermined threshold.
    Type: Application
    Filed: September 27, 2018
    Publication date: July 30, 2020
    Applicant: Swellfix UK Limited
    Inventors: John HUNTER, Anthony WILSON
  • Publication number: 20200149372
    Abstract: A power source system including a plurality of cells. The power source system uses electrical charge or current generated by a reaction in at least one of the cells to provide at least one operating material to at least one other of the cells. Optionally, the power source system uses the electrical charge generated by the reaction in the at least one of the cells to provide the at least one operating material to the at least one other of the cells only when the state of charge of the at least one of the cells is equal to or below a threshold or when the use of the cell is equal to or above a threshold. Optionally, in an initial or non-operational state, one or more or each of the cells is dry or without the at least one operating material and the power source system is configured to selectively switch at least one of the plurality of cells from the non-operational state to an operational state by providing the at least one operating material to the at least one cell.
    Type: Application
    Filed: June 14, 2018
    Publication date: May 14, 2020
    Applicant: Swellfix UK Limited
    Inventors: John HUNTER, Anthony WILSON, Matthew Ramsey THORPE, Joyce Ann ROSIE
  • Patent number: 10000518
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-ß-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: June 19, 2018
    Assignees: GE HEALTHCARE LIMITED, GE HEALTHCARE AS
    Inventors: Lill Torild Wickstrom, Dirk-Jan in't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Publication number: 20180148428
    Abstract: The present disclosure is directed to organic electroluminescent devices comprising thermally activated emission material(s) in an emission layer. The present disclosure is also directed to compounds capable of providing thermally activated delayed fluorescence, and to emission layers comprising at least one of the compounds. The compounds may be used in organic layers such as emission layers of an organic electroluminescence device such as fluorescent OLEDs.
    Type: Application
    Filed: May 27, 2016
    Publication date: May 31, 2018
    Inventors: James Matthew MacDonald, Jenny Lee O'Connell, Melissa Skidmore, Andrew David Scully, Anthony Wilson, Kazunori Ueno
  • Patent number: 9969761
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: May 15, 2018
    Assignees: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: Torild Wickstrom, Dirk-Jan In't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Patent number: 9859504
    Abstract: The present disclosure generally relates to diamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes for preparing the diamine compounds and diazaborole metal complexes.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: January 2, 2018
    Inventors: Alexander Bilyk, Mark Bown, Anthony Wilson, Kazunori Ueno
  • Publication number: 20150280137
    Abstract: The present disclosure generally relates to diamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes for preparing the diamine compounds and diazaborole metal complexes.
    Type: Application
    Filed: March 30, 2015
    Publication date: October 1, 2015
    Inventors: Alexander Bilyk, Mark Bown, Anthony Wilson, Kazunori Ueno
  • Patent number: 9125954
    Abstract: The present invention provides a method for the synthesis of 18F-labelled biomolecules, which is amenable to automation. The present invention also provides a cassette for automating the method of the invention. The method of the present invention provides numerous advantages over the prior art methods. One less purification step is required as compared with known methods. Also, one less reagent is required as a particular reagent is employed in two different steps. The chemistry process is thereby simplified, the cost of goods is reduced and the burden of validation and documentation of reagents required for GMP clinical production is minimized.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: September 8, 2015
    Assignee: GE Healthcare Limited
    Inventors: Rajiv Bhalla, Anthony Wilson, Imtiaz Khan, Janne Brown
  • Patent number: 9085518
    Abstract: The present invention provides a method for the synthesis of 18F-labelled biomolecules, which is amenable to automation. The present invention also provides a cassette for automating the method of the invention. The method of the present invention provides numerous advantages over the prior art methods. One less purification step is required as compared with known methods. Also, in a preferred embodiment, one less reagent is required as a particular reagent is employed in two different steps. The chemistry process is thereby simplified, the cost of goods is reduced and the burden of validation and documentation of reagents required for GMP clinical production is minimized.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: July 21, 2015
    Assignee: GE Healthcare Limited
    Inventors: Robert James Domett Nairne, Rajiv Bhalla, Imtiaz Khan, Jane Brown, Anthony Wilson, Andres Black
  • Patent number: 9061080
    Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: June 23, 2015
    Assignee: GE HEALTHCARE LIMITED
    Inventors: Duncan Hiscock, Bard Indrevoll, Peter Iveson, Matthias Eberhard Glaser, Rajiv Bhalla, Anthony Wilson
  • Patent number: 9017541
    Abstract: The present invention relates to the electrodeposition of elemental zirconium at a temperature of less than 100° C. from a mixture of a Lewis acid, a zirconium salt and an ionic liquid.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: April 28, 2015
    Assignee: Astron Advanced Materials Limited
    Inventors: Kenneth Seddon, Geetha Srinivasen, Anthony Wilson
  • Publication number: 20150018541
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Application
    Filed: April 22, 2014
    Publication date: January 15, 2015
    Applicants: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: Torild WICKSTROM, DIRK-JAN IN'T VELD, NIGEL JOHN OSBORN, JULIAN GRIGG, ANTHONY WILSON
  • Publication number: 20140243555
    Abstract: The present invention provides a method for the synthesis of 18F-labelled biomolecules, which is amenable to automation. The present invention also provides a cassette for automating the method of the invention. The method of the present invention provides numerous advantages over the prior art methods. One less purification step is required as compared with known methods. Also, in a preferred embodiment, one less reagent is required as a particular reagent is employed in two different steps. The chemistry process is thereby simplified, the cost of goods is reduced and the burden of validation and documentation of reagents required for GMP clinical production is minimised.
    Type: Application
    Filed: October 15, 2012
    Publication date: August 28, 2014
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Robert James Domett Nairne, Rajiv Bhalla, Imtiaz Khan, Jane Brown, Anthony Wilson, Andres Black
  • Publication number: 20140235861
    Abstract: The present invention provides a method for the synthesis of 18F-labelled biomolecules, which is amenable to automation. The present invention also provides a cassette for automating the method of the invention. The method of the present invention provides numerous advantages over the prior art methods. One less purification step is required as compared with known methods. Also, one less reagent is required as a particular reagent is employed in two different steps. The chemistry process is thereby simplified, the cost of goods is reduced and the burden of validation and documentation of reagents required for GMP clinical production is minimised.
    Type: Application
    Filed: October 15, 2012
    Publication date: August 21, 2014
    Applicant: GE HEALTHCARE LIMITED
    Inventors: RAJIV Bhalla, Anthony Wilson, Imtiaz Khan, Janne Brown
  • Publication number: 20140097078
    Abstract: A click chemistry process to be performed with an automated synthesis device using a synthesis cassette includes the steps of performing a chemical reaction in a first vessel at a first elevated temperature, heating the first vessel to a second elevated temperature to cause distillation, delivering a distilled reaction product from the first vessel to a second vessel, performing a click chemistry reaction with the distilled reaction product in the second vessel, purifying the click chemistry product, and formulating a final product from the purified click chemistry product. A cassette and a kit of parts for performing the process are also provided.
    Type: Application
    Filed: June 7, 2012
    Publication date: April 10, 2014
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Lisa Iddon, Rajiv Bhalla, ANTHONY Wilson
  • Publication number: 20130295010
    Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.
    Type: Application
    Filed: December 19, 2011
    Publication date: November 7, 2013
    Inventors: Duncan Hiscock, Bard Indrevoll, Peter Iveson, Matthias Eberhard Glaser, Rajiv Bhalla, Anthony Wilson
  • Publication number: 20130287685
    Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.
    Type: Application
    Filed: December 19, 2011
    Publication date: October 31, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Duncan Hiscock, Brad Indrevoll, Peter Iveson, Matthias Eberhard Glaser, Rajiv Bhalla, Anthony Wilson
  • Publication number: 20130202530
    Abstract: Novel radiotracer(s) for Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) imaging of disease states related to altered choline metabolism (e.g., tumor imaging of prostate, breast, brain, esophageal, ovarian, endometrial, lung and prostate cancer—primary tumor, nodal disease or metastases). The present invention also describes intermediate(s), pre-cursor(s), pharmaceutical composition(s), methods of making, and methods of use of the novel radiotracer(s).
    Type: Application
    Filed: September 20, 2011
    Publication date: August 8, 2013
    Applicants: IMPERIAL COLLEGE, GE HEALTHCARE LIMITED
    Inventors: Eric Ofori Aboagye, Edward George Robins, Graham Smith, Yongjun Zhao, David Turton, Anthony Wilson, Rajiv Bhalla, Diana Brickute